Back to Search Start Over

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Authors :
Mat J.A.P. Daemen
Lale Tokgozoglu
Luis Masana
Brian A. Ference
Alberico L. Catapano
Ronald M. Krauss
Frederick J. Raal
Ulrich Laufs
Heribert Schunkert
Jan Borén
Chris J. Packard
Gerard Pasterkamp
Ulf Landmesser
Børge G. Nordestgaard
Jay D. Horton
Eric Bruckert
Olov Wiklund
Christoph J. Binder
Marja-Riitta Taskinen
Bart van de Sluis
Kausik K. Ray
Sergio Fazio
Robert A. Hegele
Ian D. Graham
M. John Chapman
Stephen J. Nicholls
Gerald F. Watts
Linda L. Demer
Henry N. Ginsberg
Jacob F. Bentzon
Gestionnaire, Hal Sorbonne Université
Sahlgrenska Academy at University of Gothenburg [Göteborg]
Service d'Endocrinologie, Métabolisme et Prévention des Maladies Cardio-vasculaires [CHU Pitié-Salpêtrière]
CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Children's Hospital Oakland Research Institute (CHORI)
University of California [San Francisco] (UC San Francisco)
University of California (UC)
University of Glasgow
Aarhus University [Aarhus]
Centro Nacional de Investigaciones Cardiovasculares Carlos III [Madrid, Spain] (CNIC)
Instituto de Salud Carlos III [Madrid] (ISC)
Medizinische Universität Wien = Medical University of Vienna
Amsterdam UMC - Amsterdam University Medical Center
Schulich School of Medicine and Dentistry
University of Western Ontario (UWO)
Monash University [Melbourne]
Copenhagen University Hospital
The University of Western Australia (UWA)
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Service de Nutrition [CHU Pitié-Salpétrière]
Institut E3M [CHU Pitié-Salpêtrière]
Oregon Health and Science University [Portland] (OHSU)
University of Cambridge [UK] (CAM)
University of Bristol [Bristol]
Trinity College Dublin
University of Texas Southwestern Medical Center
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
Berlin Institute of Health (BIH)
Universität Leipzig [Leipzig]
Universitat Rovira i Virgili
University Medical Center [Utrecht]
University of the Witwatersrand [Johannesburg] (WITS)
Imperial College London
Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM)
German Center for Cardiovascular Research (DZHK)
Helsingin yliopisto = Helsingfors universitet = University of Helsinki
University Medical Center Groningen [Groningen] (UMCG)
Hacettepe University = Hacettepe Üniversitesi
Università degli Studi di Milano = University of Milan (UNIMI)
Columbia University [New York]
European Atherosclerosis Society
Center for Liver, Digestive and Metabolic Diseases (CLDM)
Restoring Organ Function by Means of Regenerative Medicine (REGENERATE)
Service d’Endocrinologie, Métabolisme et Prévention des Risques Cardio-Vasculaires [CHU Pitié-Salpêtrière]
University of California [San Francisco] (UCSF)
University of California
Amsterdam UMC
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)
Service de nutrition [CHU Pitié-Salpétrière]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP]
Technische Universität München [München] (TUM)
University of Helsinki
Università degli Studi di Milano [Milano] (UNIMI)
HUS Heart and Lung Center
Clinicum
CAMM - Research Program for Clinical and Molecular Metabolism
Research Programs Unit
Faculty of Medicine
Source :
European Heart Journal, European Heart Journal, 2020, 41 (24), pp.2313-2330. ⟨10.1093/eurheartj/ehz962⟩, Borén, J, Chapman, M J, Krauss, R M, Packard, C J, Bentzon, J F, Binder, C J, Daemen, M J, Demer, L L, Hegele, R A, Nicholls, S J, Nordestgaard, B G, Watts, G F, Bruckert, E, Fazio, S, Ference, B A, Graham, I, Horton, J D, Landmesser, U, Laufs, U, Masana, L, Pasterkamp, G, Raal, F J, Ray, K K, Schunkert, H, Taskinen, M R, van de Sluis, B, Wiklund, O, Tokgozoglu, L, Catapano, A L & Ginsberg, H N 2020, ' Low-density lipoproteins cause atherosclerotic cardiovascular disease : pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel ', European Heart Journal, vol. 41, no. 24, pp. 2313-2330 . https://doi.org/10.1093/eurheartj/ehz962, Borén, J, John Chapman, M, Krauss, R M, Packard, C J, Bentzon, J F, Binder, C J, Daemen, M J, Demer, L L, Hegele, R A, Nicholls, S J, Nordestgaard, B G, Watts, G F, Bruckert, E, Fazio, S, Ference, B A, Graham, I, Horton, J D, Landmesser, U, Laufs, U, Masana, L, Pasterkamp, G, Raal, F J, Ray, K K, Schunkert, H, Taskinen, M R, van de Sluis, B, Wiklund, O, Tokgozoglu, L, Catapano, A L & Ginsberg, H N 2020, ' Low-density lipoproteins cause atherosclerotic cardiovascular disease : Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel ', European Heart Journal, vol. 41, no. 24, pp. 2313-2330 . https://doi.org/10.1093/eurheartj/ehz962, Repisalud, Instituto de Salud Carlos III (ISCIII), European Heart Journal, 41(24):ehz962, 2313-+. Oxford University Press, European Heart Journal, Oxford University Press (OUP): Policy B, 2020, 41 (24), pp.2313-2330. ⟨10.1093/eurheartj/ehz962⟩
Publication Year :
2020
Publisher :
Oxford University Press (OUP), 2020.

Subjects

Subjects :
0301 basic medicine
Heart disease
Statement (logic)
SMOOTH-MUSCLE-CELLS
[SDV]Life Sciences [q-bio]
030204 cardiovascular system & hematology
Bioinformatics
MESH: Atherosclerosis
Coronary artery disease
0302 clinical medicine
Low density
1102 Cardiorespiratory Medicine and Haematology
ComputingMilieux_MISCELLANEOUS
Atherosclerotic cardiovascular disease
APOPTOTIC CELL ACCUMULATION
Pathophysiology
ddc
3. Good health
[SDV] Life Sciences [q-bio]
Cardiovascular Diseases
Current Opinion
CORONARY-ARTERY-DISEASE
Cardiology and Cardiovascular Medicine
Translational Medicine
MESH: Cholesterol, LDL
Consensus
MONOCYTE-DERIVED MACROPHAGES
education
HEART-DISEASE
LIPID-LOWERING THERAPY
Lipid-lowering therapy
03 medical and health sciences
ESTER TRANSFER PROTEIN
HIGH-INTENSITY STATIN
medicine
Humans
CHOLESTEROL-FED RABBITS
MESH: Consensus
MESH: Humans
business.industry
MESH: Cardiovascular Diseases
1103 Clinical Sciences
Cholesterol, LDL
medicine.disease
Atherosclerosis
030104 developmental biology
Cardiovascular System & Hematology
3121 General medicine, internal medicine and other clinical medicine
European atherosclerosis society
business
TRIGLYCERIDE-RICH LIPOPROTEINS

Details

Language :
English
ISSN :
0195668X and 15229645
Database :
OpenAIRE
Journal :
European Heart Journal, European Heart Journal, 2020, 41 (24), pp.2313-2330. ⟨10.1093/eurheartj/ehz962⟩, Borén, J, Chapman, M J, Krauss, R M, Packard, C J, Bentzon, J F, Binder, C J, Daemen, M J, Demer, L L, Hegele, R A, Nicholls, S J, Nordestgaard, B G, Watts, G F, Bruckert, E, Fazio, S, Ference, B A, Graham, I, Horton, J D, Landmesser, U, Laufs, U, Masana, L, Pasterkamp, G, Raal, F J, Ray, K K, Schunkert, H, Taskinen, M R, van de Sluis, B, Wiklund, O, Tokgozoglu, L, Catapano, A L & Ginsberg, H N 2020, ' Low-density lipoproteins cause atherosclerotic cardiovascular disease : pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel ', European Heart Journal, vol. 41, no. 24, pp. 2313-2330 . https://doi.org/10.1093/eurheartj/ehz962, Borén, J, John Chapman, M, Krauss, R M, Packard, C J, Bentzon, J F, Binder, C J, Daemen, M J, Demer, L L, Hegele, R A, Nicholls, S J, Nordestgaard, B G, Watts, G F, Bruckert, E, Fazio, S, Ference, B A, Graham, I, Horton, J D, Landmesser, U, Laufs, U, Masana, L, Pasterkamp, G, Raal, F J, Ray, K K, Schunkert, H, Taskinen, M R, van de Sluis, B, Wiklund, O, Tokgozoglu, L, Catapano, A L & Ginsberg, H N 2020, ' Low-density lipoproteins cause atherosclerotic cardiovascular disease : Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel ', European Heart Journal, vol. 41, no. 24, pp. 2313-2330 . https://doi.org/10.1093/eurheartj/ehz962, Repisalud, Instituto de Salud Carlos III (ISCIII), European Heart Journal, 41(24):ehz962, 2313-+. Oxford University Press, European Heart Journal, Oxford University Press (OUP): Policy B, 2020, 41 (24), pp.2313-2330. ⟨10.1093/eurheartj/ehz962⟩
Accession number :
edsair.doi.dedup.....3592e2e137199736d6a2ba602a2b12f5
Full Text :
https://doi.org/10.1093/eurheartj/ehz962⟩
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details